Behavioral Use of Andrographis paniculata and Its Efficacy in Treating COVID-19 Among Regular Herb Users in Thailand
DOI:
https://doi.org/10.61705/3wer0p03Keywords:
Efficacy of Andrographis paniculata, COVID-19Abstract
This study investigates the behavioral patterns and efficacy of Andrographis paniculata (AP) usage during the COVID-19 pandemic among regular herb users aged 40 and above in Thailand. Utilizing qualitative research methods, including in-depth interviews, the study explores the factors influencing AP use and the outcomes experienced. The findings reveal a significant increase in AP consumption as a preventative measure against COVID-19, with participants often exceeding recommended doses. The study highlights high levels of satisfaction with AP's effectiveness in both preventing and treating COVID-19 symptoms.
References
Chinsoi, P. (2020). Herbal medicine: Challenge of sustainable development. In R. Chantraket (Ed.), The 17th National Academic Conference of Thai Traditional, Folk, and Alternative Medicines: Nuad Thai & Thai Herbs Towards Good Health for All (pp. 148-150). Nonthaburi, Thailand.
Ramphaiboon, P., Charoensup, R., Sunsern, R., & Kanthawee, P. (2018). Effectiveness of the developing health literacy focusing on herbal and herbal product program among elderly people with hypertension at Mae-Chan District, Chiang Rai Province. Chiangrai Medical Journal, 10(1), 81-92.
Chaichanawirote, & Vithayachockitikhun, N. (2015). Medication use behavior among older Thai adults. Journal of Nursing and Health Science, 9(1), 32-46.
Caceres, D. D., Hancke, J. L., Burgos, R. A., & Wikman, G. K. (1997). Prevention of common colds with Andrographis paniculata dried extract: A pilot double-blind trial. Phytomedicine, 4(2), 101-104. https://doi.org/10.1016/S0944-7113(97)80051-7
Rajanna, M., Bharathi, B., Shivakumar, B. R., Deepak, M., Prashanth, D. S., Prabakaran, D., et al. (2021). Immunomodulatory effects of Andrographis paniculata extract in healthy adults: An open-label study. Journal of Ayurveda and Integrative Medicine, 12(3), 529-534. https://doi.org/10.1016/j.jaim.2021.06.004
Benjaponpitak, A., Visithanon, K., Sawaengtham, T., Thaneerat, T., & Wanaratna, K. (2021). Short communication on use of andrographis herb for the treatment of COVID-19 patients. Journal of Thai Traditional & Alternative Medicine, 19(1), 229-233.
Department of Thai Traditional and Alternative Medicine. (2021). Instruction for Andrographis paniculata use for COVID-19 outbreak. Bangkok: Samcharoen Panich.
Nastasi, B. K., & Schensul, S. L. (2005). Contributions of qualitative research to the validity of intervention research. Journal of School Psychology, 43(3), 177-195. https://doi.org/10.1016/j.jsp.2005.04.003
Sutheewasinnon, P., & Pasunon, P. (2016). Sampling strategies for qualitative research. Parichart Journal Thaksin University, 29(2), 31-48.
Cheawjindakarn, B. (2018). Qualitative case study research techniques. Liberal Arts Review, 13(25), 103-118.
Karnkunwithit, P., & Srisangkhajorn, K. (2019). 101 home herbal medicine. Chonburi: Pro Ampine.
Shang, Y.-X., Shen, C., Stub, T., Zhu, S.-J., Qiao, S.-Y., Li, Y.-Q., Wang, R.-T., Li, J., & Liu, J.-P. (2022). Adverse effects of andrographolide derivative medications compared to the safe use of herbal preparations of Andrographis paniculata: Results of a systematic review and meta-analysis of clinical studies. Frontiers in Pharmacology, 13, 773282. https://doi.org/10.3389/fphar.2022.773282
Worakunphanich, W., Thavorncharoensap, M., Youngkong, S., Thadanipon, K., & Thakkinstian, A. (2021). Safety of Andrographis paniculata: A systematic review and meta-analysis. Pharmacoepidemiology and Drug Safety, 30(6), 727-739. https://doi.org/10.1002/pds.5190
Kbar, S. (2011). Andrographis paniculata: A review of pharmacological activities and clinical effects. Alternative Medicine Review, 16, 66-77.
Center for Drug Evaluation. (2005a). The technical guidelines of the acute toxicity test for Chinese medicine and natural medicine (NMPA, Z-GPT2-1).
Center for Drug Evaluation. (2005b). The technical guidelines of the chronic toxicity test for Chinese medicine and natural medicine (NMPA, Z-GPT3-1).
Benoy, G. K., Animesh, D. K., Aninda, M., Priyanka, D. K., & Sandip, H. (2012). An overview of Andrographis paniculata (Burm.F.) Nees. International Journal of Research in Ayurveda and Pharmacy, 3(6), 752-760.
World Health Organization. (2002). WHO monographs on selected medicinal plants (Vol. 2, pp.12-24). Geneva: World Health Organization.
Sagadevan, P., Suresh, S. N., Ranjithkumar, R., Rathishkumar, S., Sathish, S., & Chandarshekar, B. (2015). Traditional use of Andrographis paniculata: Review and perspectives. International Journal of Biosciences and Nanosciences, 2(3), 123-131.
Kligler, B., Ulbricht, C., Basch, E., & Natural Standard Research Collaboration. (2006). Andrographis paniculata for the treatment of upper respiratory infection: A systematic review by the Natural Standard Research Collaboration. Explore, 2(1), 25-29.
World Health Organization. (2022). WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/
Huang, J., Tao, G., Liu, J., Cai, J., Huang, Z., & Chen, J.-X. (2020). Current prevention of COVID-19: Natural products and herbal medicine. Frontiers in Pharmacology, 11, 588508. https://doi.org/10.3389/fphar.2020.588508
Sareer, O., Ahmad, S., & Umar, S. (2014). Andrographis paniculata: A critical appraisal of extraction, isolation and quantification of andrographolide and other active constituents. Natural Product Research, 28(11), 2081–2101. https://doi.org/10.1080/14786419.2014.924004
Yu, K.,Liang, P,Yu, H., Liu, H.,Guo, J.Yan,X., Li, Z.,Li,G., Wang,Y&Wang, C. (2024). Integrating transcriptome and chemical analyses to provide insights into biosynthesis of terpenoids and flavonoids in the medicinal industrial crop Andrographis paniculata and its antiviral medicinal parts. Molecules, 29(4), 852. https://doi.org/10.3390/molecules29040852
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 International Journal of Medical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.